AYTU BIOPHARMA, INC Operating Cash Flow
AYTU BIOPHARMA, INC (AYTU) reported Operating Cash Flow of $3.28 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-09-22
- AYTU BIOPHARMA, INC net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $4.41M, a 57.19% increase year-over-year.
- AYTU BIOPHARMA, INC net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$4.18M.
- AYTU BIOPHARMA, INC net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $3.67M, a 26.51% increase year-over-year.
- AYTU BIOPHARMA, INC net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$618.00K.
- AYTU BIOPHARMA, INC net cash provided by (used in) operating activities for fiscal 2026 was $3.28M.
- AYTU BIOPHARMA, INC net cash provided by (used in) operating activities for fiscal 2025 was -$1.94M.
- AYTU BIOPHARMA, INC net cash provided by (used in) operating activities for fiscal 2024 was -$1.39M.
- AYTU BIOPHARMA, INC net cash provided by (used in) operating activities for fiscal 2023 was -$5.13M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed | Net Cash Provided by (Used in) Operating Activities 81 month | Net Cash Provided by (Used in) Operating Activities 84 month | Net Cash Provided by (Used in) Operating Activities 87 month | Net Cash Provided by (Used in) Operating Activities 90 month | Net Cash Provided by (Used in) Operating Activities 93 month | Net Cash Provided by (Used in) Operating Activities 96 month | Net Cash Provided by (Used in) Operating Activities 99 month | Net Cash Provided by (Used in) Operating Activities 102 month | Net Cash Provided by (Used in) Operating Activities 105 month | Net Cash Provided by (Used in) Operating Activities 108 month | Net Cash Provided by (Used in) Operating Activities 111 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $224.00K derived: sum of 2 quarters · filed 2026-09-22 | $3.90M derived: sum of 3 quarters · filed 2026-09-22 | $3.28M 10-K · filed 2026-09-22 | |||||||||||||||
| 2026-03-31 | -$4.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$507.00K derived: sum of 2 quarters · filed 2026-05-13 | -$1.13M 10-Q · filed 2026-05-13 | $1.68M derived: sum of 4 quarters · filed 2026-09-22 | |||||||||||||||
| 2025-12-31 | $3.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $3.06M 10-Q · filed 2026-02-03 | $5.86M derived: sum of 3 quarters · filed 2026-09-22 | -$595.00K derived: sum of 4 quarters · filed 2026-09-22 | |||||||||||||||
| 2025-09-30 | -$618.00K 10-Q · filed 2025-11-13 | $2.19M derived: sum of 2 quarters · filed 2026-09-22 | -$4.27M derived: sum of 3 quarters · filed 2026-09-22 | -$1.36M derived: sum of 4 quarters · filed 2026-09-22 | |||||||||||||||
| 2025-06-30 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | -$3.65M derived: sum of 2 quarters · filed 2026-09-22 | -$747.00K derived: sum of 3 quarters · filed 2026-09-22 | -$1.94M 10-K · filed 2026-09-22 | |||||||||||||||
| 2025-03-31 | -$6.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$3.55M derived: sum of 2 quarters · filed 2026-05-13 | -$4.74M 10-Q · filed 2026-05-13 | -$5.53M derived: sum of 4 quarters · filed 2026-05-13 | |||||||||||||||
| 2024-12-31 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $1.72M 10-Q · filed 2026-02-03 | $927.00K derived: sum of 3 quarters · filed 2026-02-03 | $673.00K derived: sum of 4 quarters · filed 2026-02-03 | |||||||||||||||
| 2024-09-30 | -$1.19M 10-Q · filed 2025-11-13 | -$1.98M derived: sum of 2 quarters · filed 2025-11-13 | -$1.19M 10-Q · filed 2024-11-13 | -$2.37M derived: sum of 4 quarters · filed 2025-11-13 | |||||||||||||||
| 2024-06-30 | -$788.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | -$1.04M derived: sum of 2 quarters · filed 2025-09-23 | -$1.18M derived: sum of 3 quarters · filed 2025-09-23 | -$1.39M 10-K · filed 2025-09-23 | |||||||||||||||
| 2024-03-31 | -$254.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | -$389.00K derived: sum of 2 quarters · filed 2025-05-14 | -$600.00K 10-Q · filed 2025-05-14 | $8.77M derived: sum of 4 quarters · filed 2025-05-14 | |||||||||||||||
| 2023-12-31 | -$135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12 | -$346.00K 10-Q · filed 2025-02-12 | $9.02M derived: sum of 3 quarters · filed 2025-02-12 | $6.11M derived: sum of 4 quarters · filed 2025-02-12 | |||||||||||||||
| 2023-09-30 | -$211.00K 10-Q · filed 2023-11-14 | $9.15M derived: sum of 2 quarters · filed 2024-09-26 | -$211.00K 10-Q · filed 2024-11-13 | $3.81M derived: sum of 4 quarters · filed 2024-09-26 | |||||||||||||||
| 2023-06-30 | $9.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-26 | $6.46M derived: sum of 2 quarters · filed 2024-09-26 | $4.02M derived: sum of 3 quarters · filed 2024-09-26 | -$5.13M 10-K · filed 2024-09-26 | |||||||||||||||
| 2023-03-31 | -$2.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | -$5.35M derived: sum of 2 quarters · filed 2024-05-15 | -$14.49M 10-Q · filed 2024-05-15 | -$21.59M derived: sum of 4 quarters · filed 2024-05-15 | |||||||||||||||
| 2022-12-31 | -$2.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | -$11.59M 10-Q · filed 2024-02-14 | -$18.68M derived: sum of 3 quarters · filed 2024-02-14 | -$27.80M derived: sum of 4 quarters · filed 2024-02-14 | |||||||||||||||
| 2022-09-30 | -$9.15M 10-Q · filed 2023-11-14 | -$16.24M derived: sum of 2 quarters · filed 2023-11-14 | -$25.36M derived: sum of 3 quarters · filed 2023-11-14 | -$34.18M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||||||
| 2022-06-30 | -$7.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-12 | -$16.21M derived: sum of 2 quarters · filed 2023-10-12 | -$25.03M derived: sum of 3 quarters · filed 2023-10-12 | -$28.82M 10-K · filed 2023-10-12 | |||||||||||||||
| 2022-03-31 | -$9.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | -$17.94M derived: sum of 2 quarters · filed 2023-05-11 | -$21.73M 10-Q · filed 2023-05-11 | -$28.00M derived: sum of 4 quarters · filed 2023-05-11 | |||||||||||||||
| 2021-12-31 | -$8.82M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-02-21 | -$12.61M 10-Q · filed 2023-02-21 | -$18.89M derived: sum of 3 quarters · filed 2023-02-21 | $810.00K derived: sum of 4 quarters · filed 2023-02-21 | |||||||||||||||
| 2021-09-30 | -$3.79M 10-Q/A · filed 2023-02-21 | -$10.07M derived: sum of 2 quarters · filed 2023-02-21 | $9.63M derived: sum of 3 quarters · filed 2023-02-21 | $6.71M derived: sum of 4 quarters · filed 2023-02-21 | |||||||||||||||
| 2021-06-30 | -$6.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $13.42M derived: sum of 2 quarters · filed 2022-09-27 | $10.50M derived: sum of 3 quarters · filed 2022-09-27 | -$25.96M 10-K · filed 2022-09-27 | |||||||||||||||
| 2021-03-31 | $19.70M 10-Q · filed 2021-05-17 | $16.78M derived: sum of 2 quarters · filed 2022-02-14 | -$19.69M 10-Q · filed 2022-05-16 | -$19.68M 10-Q · filed 2021-05-17 | $1.03M derived: sum of 4 quarters · filed 2022-02-14 | ||||||||||||||
| 2020-12-31 | -$2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | -$10.91M 10-Q · filed 2022-02-14 | -$10.90M 10-Q · filed 2021-02-11 | -$18.67M derived: sum of 3 quarters · filed 2022-02-14 | $1.93M derived: sum of 4 quarters · filed 2022-02-14 | ||||||||||||||
| 2020-09-30 | -$7.98M 10-Q · filed 2021-11-15 | -$7.97M 10-Q · filed 2020-11-12 | -$15.75M derived: sum of 2 quarters · filed 2021-11-15 | $4.85M derived: sum of 3 quarters · filed 2021-11-15 | -$1.25M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||||||
| 2020-06-30 | -$7.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $12.84M derived: sum of 2 quarters · filed 2021-09-28 | $6.74M derived: sum of 3 quarters · filed 2021-09-28 | -$28.37M 10-K · filed 2021-09-28 | -$28.37M 10-K · filed 2020-10-06 | ||||||||||||||
| 2020-03-31 | $20.60M 10-Q · filed 2021-05-17 | $14.50M derived: sum of 2 quarters · filed 2021-05-17 | -$20.61M 10-Q · filed 2021-05-17 | $8.04M derived: sum of 4 quarters · filed 2021-05-17 | |||||||||||||||
| 2019-12-31 | -$6.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-11 | -$9.09M 10-Q · filed 2021-02-11 | -$12.56M derived: sum of 3 quarters · filed 2021-02-11 | -$15.87M derived: sum of 4 quarters · filed 2021-02-11 | |||||||||||||||
| 2019-09-30 | -$2.99M 10-Q · filed 2020-11-12 | -$6.46M derived: sum of 2 quarters · filed 2020-11-12 | -$9.77M derived: sum of 3 quarters · filed 2020-11-12 | -$14.07M derived: sum of 4 quarters · filed 2020-11-12 | |||||||||||||||
| 2019-06-30 | -$3.47M derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | -$6.78M derived: sum of 2 quarters · filed 2020-10-06 | -$11.09M derived: sum of 3 quarters · filed 2020-10-06 | -$13.83M 10-K · filed 2020-10-06 | |||||||||||||||
| 2019-03-31 | -$3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | -$7.61M derived: sum of 2 quarters · filed 2020-05-15 | -$10.36M 10-Q · filed 2020-05-15 | -$14.90M derived: sum of 4 quarters · filed 2020-05-15 | |||||||||||||||
| 2018-12-31 | -$4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | -$7.05M 10-Q · filed 2020-02-14 | -$11.59M derived: sum of 3 quarters · filed 2020-02-14 | -$15.67M derived: sum of 4 quarters · filed 2020-02-14 | |||||||||||||||
| 2018-09-30 | -$2.74M 10-Q · filed 2019-11-14 | -$7.29M derived: sum of 2 quarters · filed 2019-11-14 | -$11.37M derived: sum of 3 quarters · filed 2019-11-14 | -$14.47M derived: sum of 4 quarters · filed 2019-11-14 | |||||||||||||||
| 2018-06-30 | -$4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | -$8.62M derived: sum of 2 quarters · filed 2019-09-26 | -$11.72M derived: sum of 3 quarters · filed 2019-09-26 | -$15.94M 10-K · filed 2019-09-26 | |||||||||||||||
| 2018-03-31 | -$4.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-14 | -$7.18M derived: sum of 2 quarters · filed 2019-05-14 | -$11.40M 10-Q · filed 2019-05-14 | ||||||||||||||||
| 2017-12-31 | -$3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-14 | -$7.32M 10-Q · filed 2019-05-14 | |||||||||||||||||
| 2017-09-30 | -$4.22M 10-Q · filed 2018-11-07 | ||||||||||||||||||
| 2017-06-30 | -$13.83M 10-K · filed 2018-09-06 | ||||||||||||||||||
| 2015-02-28 | -$13.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-15 | -$22.72K 10-Q · filed 2015-04-15 | |||||||||||||||||
| 2014-11-30 | -$9.33K 10-Q · filed 2015-01-12 | ||||||||||||||||||
| 2014-05-31 | -$14.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-10 | -$22.75K derived: sum of 2 quarters · filed 2015-04-15 | -$29.61K 10-Q · filed 2014-07-10 | -$34.84K derived: sum of 4 quarters · filed 2015-04-15 | -$353.10K 10-Q · filed 2014-07-10 | ||||||||||||||
| 2014-02-28 | -$8.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-15 | -$15.19K 10-Q · filed 2015-04-15 | -$20.43K derived: sum of 3 quarters · filed 2015-04-15 | -$35.70K derived: sum of 4 quarters · filed 2015-04-15 | -$338.68K 10-Q · filed 2014-04-11 | ||||||||||||||
| 2013-11-30 | -$6.86K 10-Q · filed 2015-01-12 | -$12.09K derived: sum of 2 quarters · filed 2015-01-12 | -$27.36K derived: sum of 3 quarters · filed 2015-01-12 | -$35.65K derived: sum of 4 quarters · filed 2015-01-12 | -$330.35K 10-Q · filed 2014-01-10 | ||||||||||||||
| 2013-08-31 | -$5.23K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | -$20.51K derived: sum of 2 quarters · filed 2014-11-26 | -$28.79K derived: sum of 3 quarters · filed 2014-11-26 | -$37.70K 10-K · filed 2014-11-26 | -$323.49K 10-K · filed 2014-11-26 | ||||||||||||||
| 2013-05-31 | -$15.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-10 | -$23.55K derived: sum of 2 quarters · filed 2014-07-10 | -$32.47K 10-Q · filed 2014-07-10 | -$45.03K derived: sum of 4 quarters · filed 2014-11-26 | -$318.26K 10-Q · filed 2013-06-28 | ||||||||||||||
| 2013-02-28 | -$8.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-04-11 | -$17.20K 10-Q · filed 2014-04-11 | -$29.76K derived: sum of 3 quarters · filed 2014-11-26 | -$35.67K derived: sum of 4 quarters · filed 2014-11-26 | -$302.98K 10-Q · filed 2013-04-15 | ||||||||||||||
| 2012-11-30 | -$8.92K 10-Q · filed 2014-01-10 | -$21.48K derived: sum of 2 quarters · filed 2014-11-26 | -$27.39K derived: sum of 3 quarters · filed 2014-11-26 | -$35.75K derived: sum of 4 quarters · filed 2014-11-26 | -$294.70K 10-Q · filed 2013-01-14 | ||||||||||||||
| 2012-08-31 | -$12.56K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | -$18.47K derived: sum of 2 quarters · filed 2014-11-26 | -$26.84K derived: sum of 3 quarters · filed 2014-11-26 | -$37.85K 10-K · filed 2014-11-26 | -$285.79K 10-K · filed 2012-11-29 | ||||||||||||||
| 2012-05-31 | -$5.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-06-28 | -$14.27K derived: sum of 2 quarters · filed 2013-06-28 | -$25.29K 10-Q · filed 2013-06-28 | -$34.58K derived: sum of 4 quarters · filed 2013-06-28 | -$273.22K 10-Q · filed 2012-06-26 | ||||||||||||||
| 2012-02-29 | -$8.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-04-15 | -$19.38K 10-Q · filed 2013-04-15 | -$28.68K derived: sum of 3 quarters · filed 2013-04-15 | -$46.18K derived: sum of 4 quarters · filed 2013-04-15 | -$267.32K 10-Q · filed 2012-04-12 | ||||||||||||||
| 2011-11-30 | -$11.01K 10-Q · filed 2013-01-14 | -$20.31K derived: sum of 2 quarters · filed 2013-01-14 | -$37.81K derived: sum of 3 quarters · filed 2013-01-14 | -$63.95K derived: sum of 4 quarters · filed 2013-01-14 | -$258.95K 10-Q · filed 2011-12-23 | ||||||||||||||
| 2011-08-31 | -$9.30K derived: 10-K 12 month − 10-Q 9 month · filed 2012-11-29 | -$26.80K derived: sum of 2 quarters · filed 2012-11-29 | -$52.94K derived: sum of 3 quarters · filed 2012-11-29 | -$64.82K 10-K · filed 2012-11-29 | |||||||||||||||
| 2011-05-31 | -$17.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-06-26 | -$43.64K derived: sum of 2 quarters · filed 2012-06-26 | -$55.52K 10-Q · filed 2012-06-26 | ||||||||||||||||
| 2011-02-28 | -$26.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-04-12 | -$38.02K 10-Q · filed 2012-04-12 | |||||||||||||||||
| 2010-11-30 | -$11.88K 10-Q · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |